Mayo Clinic-backed Pendulum near doubled its total funding in a round that will support increased manufacturing of its lead probiotic product.
Pendulum Therapeutics, a US-based microbiome-focused medical product developer backed by medical research and care provider Mayo Clinic, has received $54m in a series C round led by Meritech Capital. Meritech was joined by existing investors including fellow venture capital firms Sequoia Capital, True Ventures and Khosla Ventures. Craig Sherman, a general partner at Meritech, is…
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.